GoodRx Holdings, Inc.GDRXNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P15
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -11.24% |
| Q3 2025 | 2.03% |
| Q2 2025 | -0.81% |
| Q1 2025 | -2.73% |
| Q4 2024 | 1.64% |
| Q3 2024 | -4.59% |
| Q2 2024 | -7.65% |
| Q1 2024 | 5.60% |
| Q4 2023 | -2.21% |
| Q3 2023 | 17.91% |
| Q2 2023 | -0.46% |
| Q1 2023 | -4.05% |
| Q4 2022 | -16.98% |
| Q3 2022 | 5.18% |
| Q2 2022 | 3.37% |
| Q1 2022 | -11.98% |
| Q4 2021 | 7.80% |
| Q3 2021 | 2.84% |
| Q2 2021 | 3.63% |
| Q1 2021 | -70.30% |
| Q4 2020 | 139.47% |
| Q3 2020 | 198.00% |
| Q2 2020 | -15.64% |
| Q1 2020 | 17.32% |
| Q4 2019 | 19.98% |
| Q3 2019 | 19.06% |
| Q2 2019 | -0.45% |
| Q1 2019 | 0.00% |